MORGESE, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.261
EU - Europa 514
AS - Asia 249
AF - Africa 51
SA - Sud America 12
Totale 2.087
Nazione #
US - Stati Uniti d'America 1.261
IT - Italia 135
UA - Ucraina 92
SE - Svezia 82
SG - Singapore 72
IE - Irlanda 68
CN - Cina 65
TR - Turchia 48
DE - Germania 47
CI - Costa d'Avorio 40
HK - Hong Kong 35
DK - Danimarca 30
FI - Finlandia 28
KR - Corea 17
BR - Brasile 11
FR - Francia 11
GB - Regno Unito 10
MA - Marocco 9
IN - India 8
BE - Belgio 4
AT - Austria 2
NL - Olanda 2
AZ - Azerbaigian 1
EG - Egitto 1
ID - Indonesia 1
JP - Giappone 1
KG - Kirghizistan 1
LT - Lituania 1
PE - Perù 1
PT - Portogallo 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 2.087
Città #
Chandler 186
Jacksonville 114
Ashburn 108
Fairfield 99
Boardman 73
Dublin 68
Des Moines 66
New York 64
Wilmington 59
Seattle 53
Woodbridge 48
Singapore 45
Houston 41
Abidjan 40
Hong Kong 35
Cambridge 33
Ann Arbor 32
Lawrence 25
Princeton 25
Turin 25
San Mateo 24
Ancona 22
Centro 21
Los Angeles 14
Washington 12
Helsinki 11
San Diego 10
Guangzhou 9
Pune 8
Beijing 7
Norwalk 7
Falls Church 5
Brussels 4
Jiaxing 4
Shanghai 4
Wuxi 4
Kilburn 3
Montegiorgio 3
Castelraimondo 2
Chengdu 2
Dallas 2
Marche 2
Parma 2
Segrate 2
São Paulo 2
Vienna 2
Wuhan 2
Zhengzhou 2
Alfenas 1
Andrelândia 1
Arequipa 1
Aversa 1
Baku 1
Bevagna 1
Bishkek 1
Blumenau 1
Brandenburg 1
Cairo 1
Campina Grande 1
Capelinha 1
Chiswick 1
Curvelo 1
Darling 1
Falconara Marittima 1
Fayetteville 1
Foligno 1
Friesland 1
Harrison 1
Istanbul 1
Jianning 1
Lanzhou 1
Lisbon 1
London 1
Marrakesh 1
Mauá 1
Munich 1
Nuremberg 1
Pavlohrad 1
Piedade 1
Porto 1
Prescot 1
Rabat 1
San Severino Marche 1
Sano 1
São José do Rio Preto 1
Tolentino 1
Trecastelli 1
Urbisaglia 1
Weihai 1
Xi'an 1
Zibo 1
Totale 1.474
Nome #
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. 118
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 107
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 105
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 95
Electrolyte disorders in cancer patients: a systematic review 90
Gender differences and outcome of melanoma patients 89
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 86
Hyponatremia in cancer patients: Time for a new approach 85
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 85
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 85
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 84
Gender Differences and Outcomes in Melanoma Patients 84
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 83
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 81
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 78
Systemic treatment for lung carcinoids: from bench to bedside 78
High CTLA-4 expression correlates with poor prognosis in thymoma patients 76
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 74
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 74
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 73
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 72
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME 72
New findings on thymic epithelial tumors: Something is changing 70
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 69
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 57
Treatment of advanced small cell lung cancer 54
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 23
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study 11
Totale 2.158
Categoria #
all - tutte 11.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202088 0 0 0 0 0 0 0 1 20 13 12 42
2020/2021434 27 44 69 2 60 24 24 38 43 41 36 26
2021/2022188 13 29 10 5 4 22 7 9 19 23 16 31
2022/2023556 30 70 33 50 24 116 0 25 113 4 80 11
2023/2024344 43 7 23 21 44 113 4 22 3 16 3 45
2024/2025261 85 42 11 3 39 24 47 10 0 0 0 0
Totale 2.158